• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Traditional Chinese medicine compounds for the treatment of functional dyspepsia: an updated meta-analysis of randomized,double-blind, placebo-controlled trials

    2021-02-14 07:26:08LUOXioyingYANGYngMAOXinyongSONGGengqingLIUQinJIANGTinyunWEIWei
    Digital Chinese Medicine 2021年4期

    LUO Xioying, YANG Yng, MAO Xinyong, SONG Gengqing, LIU Qin, JIANG Tinyun,WEI Wei,b*

    a.Department of Spleen and Stomach Diseases, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102, China

    b.Key Laboratory of TCM Diagnosis and Treatment of Functional Gastrointestinal Diseases, Beijing 100102, China

    c.Department of Gastroenterology and Hepatology of Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio 44106,United States

    d.Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China

    Keywords Functional dyspepsia Traditional Chinese medicine compounds Placebo Effectiveness Security

    ABSTRACT Objective To evaluate the efficacy and safety of traditional Chinese medicine (TCM) compounds for the treatment of functional dyspepsia (FD).Methods The PubMed, Embase, Cochrane Library, Web of Science, Chinese Biomedical Database (CBM), Wanfang Data, China National Knowledge Infrastructure (CNKI), and China Science and Technology Journal Database (VIP) were searched to collect randomized, double-blind, and placebo-controlled trials of FD treated with TCM compounds.The search duration was from the establishment of the database to March 2, 2021.After two researchers independently screened the literature, extracted the data, and evaluated the bias risk included in the study, they used RevMan 5.4 software for meta-analysis.Results A total of 23 clinical trials were included, including 2 898 patients.Meta-analysis showed that the overall remission rate of FD treated with TCM compounds was significantly higher than that of placebo (73.8% vs.46.2%) [RR =1.50, 95% CI (1.29, 1.76), P <0.000 01].Among the single symptoms, TCM compounds were superior to the placebo in improving epigastric pain [MD = -0.99,95% CI (-1.37,-0.61), P <0.000 01], epigastric burning sensation [MD = -0.32, 95% CI (-0.59,-0.05), P =0.02], postprandial fullness discomfort [MD = -1.59, 95% CI (-1.96, -1.21),P <0.000 01], and early satiety symptoms [MD = -0.93, 95% CI(-1.32, -0.54), P <0.000 01].Compared with the placebo, TCM compounds treatment can obviously improve TCM syndrome in patients with FD [MD =-5.58, 95% CI (-7.55,-3.61), P <0.000 01],gastric emptying rate [MD =12.22, 95% CI (8.90, 15.55), P <0.000 01],and helped to improve patients' quality of life [MD = 11.27, 95% CI(0.10, 22.43), P =0.05].No severe adverse events were reported between the two groups [RR =1.34, 95% CI (0.91, 1.96), P =0.14].Conclusion Our results showed that TCM compounds treatment could significantly alleviate FD symptoms, improve gastric emptying in FD patients, and help to improve their quality of life.No severe adverse reactions have been reported in clinical applications.Due to the limitation of the quantity and quality of the included studies, the above conclusions need to be verified by more high-quality studies.

    1 Introduction

    Functional dyspepsia (FD) is a common digestive system disease.In 2016, the Rome Committee defined functional gastrointestinal diseases, including FD, as abnormal brain-intestinal interactions[1].The Rome III standard defines FD as having one or more of the following symptoms: postprandial fullness discomfort, early satiety, epigastric pain, epigastric burning sensation, and lack of any organic,systemic, or metabolic diseases that can explain these symptoms.In addition, the symptoms should occur six months ago and have symptomatic activity in the last three months[2].According to the correlation between meals and symptoms, the Rome III standard divides FD into epigastric pain syndrome(EPS) and postprandial distress syndrome (PDS).The Rome IV standard still uses this definition and slightly changes the definition of PDS[3].

    The prevalence rate of FD is approximately 16%,and the symptoms are easy to recur.The clinical treatment effect is not good, which is a considerable burden for individuals and society[4].Traditional treatment methods include proton pump inhibitors,histamine H-2 receptor antagonists, prokinetic drugs,central nervous system modulators, and lifestyle regulation.However, clinical efficacy is often difficult to meet clinical needs because of the heterogeneity of symptoms in patients with FD.Presently, there is no single drug that can completely control symptoms.The pathogenesis of FD is complex, and individual symptoms may be caused by different mechanisms.Therefore, patients with similar symptoms caused by different mechanisms may not be treated with the same drugs.Therefore, seeking effective treatment is a key problem that needs to be solved urgently[5].

    Traditional Chinese medicine (TCM) compounds have shown evident advantages in the treatment of FD.A previous meta-analysis based on randomized controlled trials (RCTs) showed that TCM is more effective than prokinetic drugs in improving the overall FD symptoms[6].In 2016, the team passed a metaanalysis.The curative effects of TCM compounds and placebo on FD were compared, highlighting the potential of TCM compounds for FD treatment.However, the number of studies included is limited,and the research evidence is not sufficient[7].In recent years, an increasing number of scholars have paid attention to the therapeutic effect of TCM on FD.Therefore, this study is based on randomized,double-blind, and placebo-controlled clinical trials.Based on previous studies, the literature has been updated, and more attention has been paid to improving TCM compounds in objective indicators and specific symptoms.The clinical efficacy and safety of TCM compounds in treating FD were systematically evaluated with the aim of drawing a higher level of evidence and a more objective and comprehensive evaluation conclusion to guide clinical treatment.

    2 Data and methods

    2.1 Document retrieval

    Search scope: the PubMed, Embase, Cochrane Library, Web of Science, Chinese Biomedical Database(CBM), Wanfang Data, China National Knowledge Infrastructure (CNKI), and China Science and Technology Journal Database (VIP).The retrieval time was from the establishment time of each database to March 2, 2021, and the conference papers and dissertations of related clinical trials were simultaneously retrieved in CNKI and Wanfang data resource systems.

    2.2 Retrieval strategy

    Consider the retrieval strategy in PubMed as an example.The specific retrieval formula is as follows:"(functional dyspepsia [title/abstract]) OR (postprandial distress syndrome [title/abstract]) OR (epigastric pain syndrome [title/abstract]) AND (randomized[title/abstract]) AND (placebo [title/abstract]) AND(blind [all fields]) OR (blind [all fields])" and "(Traditional Chinese Medicine[Title/Abstract])OR(Chinese Medicine [Title/Abstract]) OR (Chinese Herbal Medicine [Title/Abstract]) OR (Medicine,Chinese Traditional [Mesh]) OR (Formula [Title/Abstract]) OR (Decision [Title/Abstract]) OR (Prescription [Title/Abst] RACT) OR (table [title/abstract]) OR(capsule [title/abstract]) OR (granule [title/abstract])".

    In the Chinese database, the synonymous Chinese search words are used for replacement, and the logical relationship is the same as above.

    2.3 Inclusion criteria

    2.3.1 Types of researchRandomized, double-blind,placebo-controlled clinical trials.

    2.3.2 Subjects of studyThe subjects were patients with FD over 18 years old who met the diagnostic criteria of Rome II[8], Rome III[9], and Rome IV[10].If the research object is limited to gender and occupation,it will not be included.

    2.3.3 InterventionsTreatment group: only oral Chinese medicine compound treatment and does not involve the addition and subtraction of drug taste and dosage; there is no limit to the form of TCM (decoction, granules, capsules, etc.), and the course of medication should not be less than two weeks.

    Control group: only oral placebo control, the placebo should meet the form, character, and taste of Chinese medicine similar to the treatment group,and the course of treatment was the same as that of the treatment group.

    2.3.4 Curative effect evaluation indexMain outcome evaluation index: overall symptom remission rate.The data are extractable dichotomous variables;if the evaluation outcome index of doctors and patients is involved simultaneously, the evaluation outcome index of patients will prevail.

    Secondary outcome evaluation indexes: single symptom score, gastric emptying rate, TCM syndrome curative effect, quality of life evaluation, and adverse drug reactions.

    If the main outcome evaluation index does not meet the above requirements, the outcome evaluation index, including TCM syndrome efficacy or quality of life evaluation can also be included; studies reporting different outcome indicators from the same clinical trial were combined and included.

    2.4 Exclusion criteria

    (1) Non-Chinese and English literature; (2) the original materials are not published publicly; (3) intervention measures are interfered by other treatment measures; (4) the full text cannot be obtained, or the data is incomplete; (5) repeated published literature.

    2.5 Data extraction

    Two researchers independently read the title, abstract, and full text of the literature, and screened and included the literature according to the standard of arrangement.In the case of objection, the third party intervened to evaluate it.The extracted data included literature title, author, publication date, research source, sample size, western medicine diagnostic criteria, TCM syndrome differentiation, intervention measures, course of treatment and follow-up time, outcome evaluation index and results, and adverse reaction events.

    2.6 The quality evaluation of included literature

    Two researchers independently conducted the quality evaluation, and a third party evaluated the objections.In this study, RevMan 5.4 software was used to evaluate the bias risk of included literature.

    2.7 Statistical analysis

    We used RevMan 5.4 for merge effect analysis.Two classification variables were analyzed by relative risk(RR), and numerical variables were analyzed by mean difference (MD), all of which were expressed by 95% confidence intervals (CIs).The formula for calculating the number needed to treat (NNT) is NNT =1/[control event rate ×(1 ? RR)].

    The heterogeneity among statistics of multiple identical studies was tested by tests for heterogeneity and evaluated using theX2test combined withI2statistics.IfP>0.10 andI2<50%, the heterogeneity was considered acceptable[11].If the included research has homogeneity, the fixed effects model is used; if there is heterogeneity, a random-effect model[12]is used.

    The difference between the combined statistics of several similar studies was evaluated using the hypothesis testZtest, and it was considered to be statistically significant whenP<0.05.

    3 Results

    3.1 Retrieval results

    According to the literature retrieval strategy, 132 studies were obtained by preliminary retrieval,including 15 in Cochrane, 10 in Web of Science, 18 in PubMed, seven in Embase, 72 in CNKI, 13 in Wanfang Data, 19 in CBM, and nine in VIP.First, according to the title of the literature, the repetitive literature was eliminated (58 articles).Second, by reading the title and abstract of the literature, 68 articles were excluded, including nine reviews, one experimental article, seven research schemes, three non-randomized double-blind placebo studies, eight non-meeting diagnostic criteria, 15 articles using western medicine, nine oral studies of non-TCM compound,10 inconsistent prescriptions in the treatment group,five experimental studies related to children, and one limited gender.Finally, eight studies were screened out by reading the full text.Among them, eight articles were published repeatedly (in different languages or different article types).Finally, 29 articles were included[13-41].The specific literature screening process is shown in Figure 1.Among the 29 articles,there are six dissertations[13-15,20,23,41]and 23 journal articles[16-19,21,22,24-40], among which six articles are different results published by other similar studies.Therefore, the same studies were merged into information statistics and analysis.Table 1 shows specific combined results, and a total of 23 studies were included in the meta-analysis.

    Among the 23 studies included in the analysis, 19 were completed in China[13-23,27-36,38-41], two in Korea[24,25], and two in Japan[26,37].A total of 2 898 patients were included in the analysis, and the number of participants in each study ranged from 36 to 319,among which the proportion of male patients ranged from 29.1% to 45.7%.Twelve studies involved 17 articles[16-19,21,22,24,26-29,33,35-38,40]were multicenter studies,and the number of participating research centers ranged from 2 to 56.The basic information of the 23 studies included in the analysis is shown in Table 1.The specific drug composition of Chinese medicine compounds involved in the study is shown in Table 2.

    3.2 Included research quality

    Figure 1 Flow chart of literature screening

    The basic information of research methodology is incorporated as follows.(1) Random allocation methods: 15 studies describe the methods of generating random allocation sequences, the remaining three studies are not specifically described, and the contact authors have not responded[13,14,30,31]; (2) concealment of allocation schemes: 16 studies describe specific methods of hiding random allocation sequences, whereas the rest are not explained in detail[13,14,20,25,30-32,36]; (3) blind method (research object and treatment plan implementer): 23 studies all described the blind method for subjects and experimenters; (4) blind method (measurer of research results): seven studies involved 12 articles[16-19,21,22,25-29,35]stated that the data were managed and analyzed by a third party, whereas the rest were not explained in detail; (5) integrity of result data: nine studies involved 12 articles[16-19,21,22,25,26,28,29,36,40]clarified that Intentionality-to-Treat (ITT) was selected in the result analysis process, six studies[15,20,32,35,37,41]had incomplete information but clarified the reasons, and four studies adopted Per-protocol (PP) in the result analysis[23,33,38,39]; (6) results of selective research reports: 10 studies involved 15 articles[16-19,21,22,26-29,35-38,40]provided exact clinical trial registration information,one study[38]published the trial plan before the trial was conducted, and the trial plans of other studies could not be obtained; (7) other sources of bias: all the included studies have comparable baselines between the treatment group and the control group.In addition,eight studies involved10 articles[18,19,21,22,24,26,35,36,38,40]identified possible conflicts of interest.The results of the Cochrane risk bias assessment tool document quality assessment are shown in Figure 2.

    3.3 Analysis of statistical results

    The statistical results were described from six aspects: overall symptom relief rate, single symptom curative effect, TCM syndrome curative effect, gastric emptying rate, quality of life, and adverse reactions.

    Table 1 Continued

    Table 2 Composition of prescriptions included in the literature

    Table 2 Continued

    Table 2 Continued

    Figure 2 The quality evaluation of included research literatures

    3.3.1 Overall symptom remission rateAmong the 23 studies included, 16 studies involved 18 articles reported the overall symptom remission rate[13-22,32-36,38,39,41], totaling 1 911 cases, 1 091 cases in the Chinese medicine compound treatment group.Of these, 805 cases reported overall symptom improvement(73.8%), and 820 cases in the placebo control group,of which 379 cases reported overall symptom remission (46.2%).Compared with the two groups, the synergistic effect of the TCM compound treatment group was 27.6%, and the NNT was calculated to be 4.3, that is, one person benefited from TCM every 4.3 people treated.

    The heterogeneity test showed high heterogeneity (X2= 59.40,P< 0.000 01,I2= 75%); therefore, a randomized effect model was adopted.The results showed that the therapeutic effect of TCM compound was significantly better than that of placebo on the opposite side of overall symptom improvement [RR =1.50, 95% CI (1.29, 1.76),P<0.000 01].According to the different evaluation methods of the total effective rate, there was some homogeneity among the five studies using the TDS score (X2=5.13,P= 0.27,I2= 22%).The results of theZtest showed that the effect of the Chinese herbal compound group was more obvious, which was consistent with the overall results [RR = 1.29, 95% CI (1.14, 1.46),P<0.000 1],and there was a significant heterogeneity among the four studies using the PDS scale (X2=23.27,P<0.000 1,I2=87%).The results of theZtest were also consistent with the overall results [RR = 1.89, 95% CI (1.14,3.12),P=0.01].There was some heterogeneity among the five studies using the TCM syndrome scale (X2= 12.83,P=0.01,I2=69%), and the results of theZtest were consistent with the overall results[RR =1.85, 95% CI (1.24, 2.76),P=0.003].The other two studies used other scales, and the results showed that the effective rate of both Chinese medicine compound groups was higher; however, there was no significant difference with the placebo group (P>0.05)(Figure 3).

    3.3.2 Efficacy of single symptomAmong the included studies, there were four studies involved nine articles[16-19,21,22,27-29], which evaluated the curative effect of single symptoms of “epigastric pain, epigastric burning sensation, postprandial fullness discomfort,and early satiety”.A total of 527 patients were included, including 351 patients in the Chinese medicine compound group and 176 patients in the placebo group.The differences in single symptom scores between each group after treatment and baseline were analyzed.

    Figure 3 Meta-analysis of overall symptom relief rate of TCM compound compared with placebo

    (1) Symptom score of epigastric pain: the heterogeneity test showed homogeneity in the combined study (X2=2.31,P=0.51,I2=0%).Using the fixed effect model, theZtest showed that the improvement of epigastric pain symptoms in FD patients after treatment with TCM compound was better than that of placebo [MD = -0.99, 95% CI (-1.37, -0.61),P<0.000 01] (Figure 4).

    (2) Symptom score of epigastric burning sensation: the results of the heterogeneity test showed homogeneity (X2= 4.38,P= 0.22,I2= 32%); thus, the fixed-effect model was adopted.TheZtest showed that the effect of the Chinese medicine compound group was better than that of the placebo group in improving the symptoms of epigastric burning sensation in FD patients [MD = -0.32, 95% CI (-0.59,-0.05),P=0.02] (Figure 5).

    (3) Postprandial fullness and bloating score: there was homogeneity among the four studies (X2=1.42,P=0.70,I2=0%).Using the fixed effect model, theZtest showed that the Chinese medicine compound group was significantly better than the placebo group in improving the postprandial fullness symptoms of FD patients [MD=-1.59,95%CI(-1.96,-1.21),P< 0.000 01] (Figure 6).

    (4) Early satiety symptom score: there was homogeneity among the four studies (X2=1.34,P=0.72,I2=0%).Using the fixed effect model, the results of theZtest showed that the Chinese medicine compound group was significantly better than the placebo group in improving the early satiety symptoms of FD patients [MD = -0.93, 95% CI (-1.32, -0.54),P< 0.000 01](Figure 7).

    3.3.3 TCM Syndrome ScoreAmong the 23 studies ,there were four studies involved seven articles[13,27-31,35]with spleen deficiency and Qi stagnation syndrome,three studies involved four articles[20-22,32]with the mixed syndrome of cold and heat, two studies involved three articles[15,18,19]with spleen and stomach deficiency and cold.There was one study with liverstomach disharmony, spleen-stomach damp-heat,and spleen deficiency syndrome, respectively[14,16,41],and three studies[23,33,40]with various syndrome types such as dampness-heat of the spleen and stomach,disharmony between the liver and stomach, etc.,whereas the rest of the studies did not show clear syndrome differentiation.Among the studies on syndrome differentiation, nine studies involved 13 articles[13,16-23,30-32,41]reported TCM syndrome scores.The differences in TCM syndrome scores between the two groups after treatment and baseline were analyzed.As shown in Figure 8, the heterogeneity test showed that the heterogeneity of the combined study was large (X2=36.56,P< 0.000 1,I2=78%); thus, the random effects model was adopted.The results showed that the improvement of TCM syndromes after treatment with TCM compounds was more evident than that of placebo treatment [MD = -5.58,95% CI (-7.55,-3.61),P< 0.000 01].(Figure 8)

    Figure 4 Meta-analysis of symptom integral changes of abdominal pain on TCM compound versus placebo

    Figure 5 Meta-analysis of symptom score changes of epigastric burning sensation compared with placebo in TCM compound

    Figure 6 Meta-analysis of the changes of postprandial fullness and bloating score of TCM compound compared with placebo

    Figure 7 Meta-analysis of early satiety symptom score changes of TCM compound compared with placebo

    Figure 8 Meta-analysis of TCM syndrome integral changes between TCM compound and placebo

    3.3.4 Gastric emptying rateThree studies involved four articles[13,30,31,35]reported the gastric emptying rate.SHI[13]used radioimaging, whereas ZHONG et al.[31]and LV et al.[35]used real-time ultrasound.The heterogeneity test showed that the combined study had some homogeneity (X2=3.18,P=0.20,I2=37%); thus, the fixed-effect model was adopted.Ztest showed that the Chinese medicine compound group could improve the gastric emptying rate of FD patients better than the placebo group [MD =12.22, 95% CI(8.90, 15.55),P< 0.000 01] (Figure 9).

    3.3.5 Quality of lifeSeven studies reported an improvement in quality of life, among which two studies[26,32]were evaluated using the FD-QoL scale, and five studies involved 10 articles[16-19,21-23,27-29]were evaluated using the MOS 36-item short-form health survey (SF-36).According to the physical component summary (PCS) score and mental component summary (MCS) score provided by the SF-36, the sum of the two was extracted as the final evaluation result of the SF-36 scale.The differences between the baseline score and the TCM compound group and the placebo group were analyzed.Heterogeneity test results showed that the combined study had a certain heterogeneity (X2=41.32,P< 0.000 01,I2=83%); thus,the random effects model was adopted.Ztest results showed that the improvement trend of quality of life in the Chinese medicine compound group was better; however, there was no significant difference between the two groups [MD =11.27, 95% CI (0.10,22.43),P=0.05].The results of the heterogeneity test showed that there was homogeneity among the five studies using the SF-36 scale (X2=4.41,P=0.35,I2=9%), and the results of theZtest showed that the effect of the Chinese medicine compound group was better than that of the placebo group [MD =30.51,95% CI (8.64, 52.37),P=0.006].There was a significant heterogeneity among the three studies using the FD-QoL scale (X2=32.92,P< 0.000 01,I2=94%).The results of theZtest showed that there was no significant difference between the Chinese herbal compound group and the placebo group [MD =5.39, 95%CI (-7.03, 17.81),P=0.39] (Figure 10).

    3.3.6 Adverse eventsAmong the 23 studies included, one study[30,31]did not mention any adverse events, whereas the rest observed and evaluated adverse events.Among them, seven studies[24,26,33,36-38,40]reported the occurrence of adverse drug events, 54(7.8%) of the 690 patients involved in the trial group reported adverse reactions, and 40 (5.8%) of the 688 patients in the placebo group reported adverse reactions.The heterogeneity test showed that the combined study had homogeneity (X2=7.18,P=0.30,I2=16%).Using the fixed effect model, the results showed no significant difference in adverse reactions between the Chinese medicine compound group and placebo group [RR = 1.34, 95% CI (0.91, 1.96),P=0.14] (Figure 11).

    4 Discussion

    Figure 9 Meta-analysis of gastric emptying rate after placebo treatment compared with TCM compound

    Figure 10 Meta-analysis of quality of life after placebo treatment compared with TCM compound

    Figure 11 Meta-analysis of adverse reaction events of TCM compound versus placebo

    This study collected clinical data from randomized,double-blind, placebo-controlled trials and evaluated systematically and objectively the clinical efficacy and safety of Chinese herbal compounds for FD treatment using evidence-based medicine.In the case of symptom improvement, compared with placebo, TCM compounds can better relieve the overall symptoms of FD patients.The TDS score is a commonly used evaluation method for dyspepsia symptoms, including epigastric pain, burning sensation, postprandial fullness discomfort, early satiety,nausea, vomiting, and belching.There was some homogeneity among the five studies using the TDS score in the subgroup analysis.The results are consistent with the overall study, indicating that the research results are relatively reliable.Patients with FD often exhibit complex digestive tract symptoms.This study showed that TCM compounds have a good curative effect on the four most typical symptoms of FD.In addition, TCM syndromes can reflect the overall performance of a class of patients with similar characteristics, which is a better means of evaluating the overall therapeutic effect of TCM compounds;however, due to the lack of concentration of syndrome differentiation in this study, there is no subgroup analysis of the treatment effect of different syndrome types.However, the current TCM syndrome scale still needs to be standardized and improved,which might also be the reason for the high heterogeneity among various studies in the analysis of TCM syndrome scores in this study.Patients with functional dyspepsia often show depression and decreased quality of life[5].Studies by LV et al.[35]and TOMINAGA et al.[37]showed that TCM compounds can also improve HADS anxiety and depression scores in patients with FD.FD is a chronic disease with a long cycle and easy recurrence.In the literature included in this study, there are four studies[18,21,28,35]showing that the improvement effect of TCM compounds on FD symptoms lasts for at least four weeks; however,few research has reported the recurrence rate of FD.

    The pathogenesis of FD is complex and still not completely clear; however, it may be related to visceral hypersensitivity, gastrointestinal motility disorder, and low-grade inflammation of the duodenal mucosa caused by abnormal brain-intestinal interactions.In addition to the improvement of gastric emptying, WANG et al.[30]also found that the treatment of TCM for invigorating the spleen and regulating Qi can significantly increase the levels of serum motilin and ghrelin in FD patients with spleen deficiency and Qi stagnation syndrome, which may be one of the mechanisms for improving gastric motility.HAI[20]tested visceral sensitivity by water load combined with B-ultrasound test and found that the improvement of visceral sensitivity by TCM compound is better than placebo, which may be one of the effective mechanisms of TCM compounds in improving FD symptoms.

    The safety of TCM compounds is also worthy of attention, and no severe adverse reactions were reported in 2 898 patients included in this study.Notably, research by DU et al.[33]showed that the incidence of adverse reactions in the Houpo Paiqi Mixture group was significantly higher than that in the placebo group, and its adverse reactions were mainly mild diarrhea.The drug is composed of Houpo(Magnoliae Officinalis Cortex), Muxiang (Aucklandiae Radix), Zhishi (Aurantii Fructus Immaturus), and Dahuang (Rhei Radix et Rhizoma), and the occurrence of adverse reactions is mainly related to the pharmacological effects of the drug.Adverse reactions reported in other studies include nausea, headache, and a mild increase in alanine aminotransferase.In general, Chinese medicine compound treatment of FD has better safety; however, in clinical application, it should be reasonable to differentiate symptoms and signs and clarify the scope of application of drugs.

    5 Conclusion

    In summary, this meta-analysis shows that Chinese medicine compounds are more effective than placebo in treating FD due to the improved indigestion symptoms, CMS, gastric emptying rate, and quality of life of FD patients.There are no severe adverse reactions.However, due to the limitation of the number and quality of the included studies, the above conclusions should be further analyzed and verified.

    Acknowledgements

    We thank for the funding support from the National Natural Science Foundation of China Project (No.81820108033) and the Project of Wangjing Hospital,China Academy of Chinese Medical Sciences (No.WJYY2020-18).

    Competing interests

    The authors declare no conflict of interest.

    or卡值多少钱| 黄色成人免费大全| 亚洲国产欧美网| 久久久精品大字幕| 国产精品亚洲av一区麻豆| 国模一区二区三区四区视频| 国内毛片毛片毛片毛片毛片| 宅男免费午夜| 国产一区二区在线观看日韩 | 97人妻精品一区二区三区麻豆| 国产免费一级a男人的天堂| 九九在线视频观看精品| 岛国在线观看网站| 无限看片的www在线观看| 欧美日韩国产亚洲二区| 国产高清三级在线| 一卡2卡三卡四卡精品乱码亚洲| 日本撒尿小便嘘嘘汇集6| 在线观看免费午夜福利视频| a在线观看视频网站| 搡老妇女老女人老熟妇| 嫩草影院精品99| 久久精品国产清高在天天线| 国产不卡一卡二| 神马国产精品三级电影在线观看| 国产极品精品免费视频能看的| 欧美不卡视频在线免费观看| 欧美日本视频| 日日夜夜操网爽| 怎么达到女性高潮| 一本精品99久久精品77| 亚洲人成网站在线播| 女人被狂操c到高潮| 三级毛片av免费| 女警被强在线播放| 久久久色成人| 嫁个100分男人电影在线观看| 亚洲五月天丁香| 91久久精品国产一区二区成人 | 最后的刺客免费高清国语| 日日干狠狠操夜夜爽| 免费看美女性在线毛片视频| av在线天堂中文字幕| 88av欧美| 欧美黄色片欧美黄色片| 精品国产美女av久久久久小说| 日本 av在线| 国产精品香港三级国产av潘金莲| 日韩成人在线观看一区二区三区| 日本五十路高清| 神马国产精品三级电影在线观看| 午夜免费成人在线视频| 亚洲成人久久性| 色哟哟哟哟哟哟| 精品一区二区三区人妻视频| 老汉色∧v一级毛片| 国产亚洲精品久久久久久毛片| 波野结衣二区三区在线 | 男人舔奶头视频| 男人舔奶头视频| av天堂在线播放| 无遮挡黄片免费观看| 人人妻人人澡欧美一区二区| 国产精品久久久久久亚洲av鲁大| 国产精品一区二区免费欧美| 在线观看日韩欧美| 久久久久国内视频| 18美女黄网站色大片免费观看| 女警被强在线播放| 国内精品久久久久久久电影| 美女 人体艺术 gogo| av片东京热男人的天堂| 97超级碰碰碰精品色视频在线观看| 国产日本99.免费观看| 国产精品嫩草影院av在线观看 | 亚洲天堂国产精品一区在线| 国产在线精品亚洲第一网站| 黑人欧美特级aaaaaa片| 久久国产精品人妻蜜桃| 99热这里只有是精品50| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 日韩欧美一区二区三区在线观看| 男女下面进入的视频免费午夜| 一区福利在线观看| 丰满的人妻完整版| 国产蜜桃级精品一区二区三区| 久久精品国产亚洲av香蕉五月| 精品国产三级普通话版| 日韩欧美一区二区三区在线观看| 美女黄网站色视频| 啪啪无遮挡十八禁网站| 夜夜爽天天搞| 久久天躁狠狠躁夜夜2o2o| 午夜老司机福利剧场| 午夜精品在线福利| 久久久国产成人免费| 午夜精品久久久久久毛片777| 欧美日韩福利视频一区二区| 国产美女午夜福利| 国产中年淑女户外野战色| 日日干狠狠操夜夜爽| 亚洲精品影视一区二区三区av| 观看美女的网站| 亚洲黑人精品在线| 一本一本综合久久| 少妇人妻精品综合一区二区 | 丁香六月欧美| 看黄色毛片网站| 欧美精品啪啪一区二区三区| 婷婷精品国产亚洲av| 在线观看66精品国产| 精品不卡国产一区二区三区| 亚洲 欧美 日韩 在线 免费| 不卡一级毛片| 伊人久久大香线蕉亚洲五| 亚洲美女黄片视频| 亚洲成人中文字幕在线播放| 欧美午夜高清在线| 男女床上黄色一级片免费看| 色综合站精品国产| 最近最新中文字幕大全免费视频| 精品久久久久久久末码| 99riav亚洲国产免费| 一本一本综合久久| 51国产日韩欧美| 婷婷丁香在线五月| 级片在线观看| 久久久久久久久中文| 国产精品乱码一区二三区的特点| av福利片在线观看| av在线蜜桃| 亚洲精品在线观看二区| 国产主播在线观看一区二区| 亚洲精品美女久久久久99蜜臀| 亚洲无线在线观看| 国产黄色小视频在线观看| 一本久久中文字幕| 午夜激情欧美在线| 校园春色视频在线观看| 夜夜躁狠狠躁天天躁| 丁香六月欧美| 国产精品一区二区三区四区免费观看 | 国产成人影院久久av| 成人av在线播放网站| 久久久国产成人精品二区| 欧美国产日韩亚洲一区| 日日摸夜夜添夜夜添小说| 内射极品少妇av片p| 欧美区成人在线视频| 97碰自拍视频| 少妇丰满av| 国产国拍精品亚洲av在线观看 | 亚洲精华国产精华精| 午夜精品在线福利| av片东京热男人的天堂| 99热这里只有精品一区| 制服人妻中文乱码| 成人一区二区视频在线观看| 91在线观看av| av天堂中文字幕网| 此物有八面人人有两片| 亚洲精品成人久久久久久| 高清日韩中文字幕在线| 亚洲av日韩精品久久久久久密| 一夜夜www| 亚洲精品久久国产高清桃花| 别揉我奶头~嗯~啊~动态视频| 特大巨黑吊av在线直播| 国产又黄又爽又无遮挡在线| 久久久久免费精品人妻一区二区| 久久香蕉精品热| 国产精品影院久久| 99久久精品热视频| 琪琪午夜伦伦电影理论片6080| 叶爱在线成人免费视频播放| 桃红色精品国产亚洲av| 欧美丝袜亚洲另类 | 亚洲美女黄片视频| 岛国视频午夜一区免费看| 最近视频中文字幕2019在线8| 黄片大片在线免费观看| 国产中年淑女户外野战色| 欧美一级毛片孕妇| 一级毛片女人18水好多| 亚洲最大成人中文| 国产高潮美女av| avwww免费| 国产三级黄色录像| 成人午夜高清在线视频| 欧美xxxx黑人xx丫x性爽| 亚洲人成伊人成综合网2020| 一本精品99久久精品77| 99久久99久久久精品蜜桃| 波野结衣二区三区在线 | 哪里可以看免费的av片| 老鸭窝网址在线观看| x7x7x7水蜜桃| 中文字幕人妻熟人妻熟丝袜美 | 午夜福利18| 欧美在线黄色| 老汉色av国产亚洲站长工具| 亚洲av免费高清在线观看| 亚洲精品乱码久久久v下载方式 | 男女床上黄色一级片免费看| 精品免费久久久久久久清纯| 熟女人妻精品中文字幕| 内地一区二区视频在线| 波多野结衣巨乳人妻| 黄色日韩在线| 欧美+亚洲+日韩+国产| 18禁国产床啪视频网站| 乱人视频在线观看| 国产精品 国内视频| 很黄的视频免费| 久久久久久久亚洲中文字幕 | 国产熟女xx| 中文亚洲av片在线观看爽| 在线视频色国产色| 久久久国产精品麻豆| 黄片大片在线免费观看| 成人鲁丝片一二三区免费| 免费人成在线观看视频色| 国产乱人伦免费视频| 午夜福利18| 亚洲精品美女久久久久99蜜臀| 日本 欧美在线| 首页视频小说图片口味搜索| 可以在线观看毛片的网站| 国内精品一区二区在线观看| 大型黄色视频在线免费观看| 18禁国产床啪视频网站| 国产精品久久久久久人妻精品电影| 亚洲国产色片| 亚洲第一电影网av| 一个人看视频在线观看www免费 | 午夜精品在线福利| 日本三级黄在线观看| 精品久久久久久久人妻蜜臀av| 国产精品98久久久久久宅男小说| 亚洲乱码一区二区免费版| 亚洲内射少妇av| 男插女下体视频免费在线播放| 人妻久久中文字幕网| 午夜免费男女啪啪视频观看 | 国产黄片美女视频| 亚洲真实伦在线观看| 亚洲精品美女久久久久99蜜臀| 亚洲精品影视一区二区三区av| 性欧美人与动物交配| 可以在线观看毛片的网站| 日韩中文字幕欧美一区二区| 亚洲国产精品sss在线观看| 淫秽高清视频在线观看| 免费大片18禁| 欧美成人一区二区免费高清观看| 午夜精品在线福利| 国产视频内射| 国产欧美日韩精品一区二区| 国产亚洲精品久久久久久毛片| 中文亚洲av片在线观看爽| 99国产极品粉嫩在线观看| 床上黄色一级片| 久久午夜亚洲精品久久| 日本在线视频免费播放| 亚洲va日本ⅴa欧美va伊人久久| 男人舔奶头视频| 国产一区二区在线av高清观看| 国产精华一区二区三区| 99久久成人亚洲精品观看| 欧美不卡视频在线免费观看| 国产真人三级小视频在线观看| 久久久国产精品麻豆| 在线观看日韩欧美| 看免费av毛片| 999久久久精品免费观看国产| 国产欧美日韩一区二区三| 99国产精品一区二区蜜桃av| 国产69精品久久久久777片| 国产精品电影一区二区三区| 夜夜看夜夜爽夜夜摸| 国产高清激情床上av| 男女之事视频高清在线观看| 免费在线观看亚洲国产| 国产欧美日韩精品一区二区| 亚洲一区二区三区色噜噜| 免费电影在线观看免费观看| 午夜福利在线观看吧| 91麻豆av在线| 搞女人的毛片| 亚洲乱码一区二区免费版| 色综合站精品国产| 熟女人妻精品中文字幕| 窝窝影院91人妻| 国内少妇人妻偷人精品xxx网站| 十八禁网站免费在线| 国模一区二区三区四区视频| 黄色丝袜av网址大全| 色老头精品视频在线观看| 国产成人系列免费观看| 在线观看美女被高潮喷水网站 | 99久久精品热视频| 欧美黑人巨大hd| 国产精品 欧美亚洲| 757午夜福利合集在线观看| 亚洲自拍偷在线| 在线观看美女被高潮喷水网站 | 女生性感内裤真人,穿戴方法视频| 黄片大片在线免费观看| 日本一本二区三区精品| 成年女人看的毛片在线观看| 亚洲,欧美精品.| 中国美女看黄片| 在线播放国产精品三级| 在线观看66精品国产| 精品国产三级普通话版| 天天躁日日操中文字幕| 亚洲avbb在线观看| 色老头精品视频在线观看| www日本黄色视频网| 久久久久久久精品吃奶| 特大巨黑吊av在线直播| 国产精品国产高清国产av| 一区福利在线观看| 嫩草影院入口| 最新美女视频免费是黄的| 全区人妻精品视频| 国产精品一及| 日韩高清综合在线| 观看免费一级毛片| 国产一区二区三区视频了| 99在线人妻在线中文字幕| 国产成人aa在线观看| 精品久久久久久久人妻蜜臀av| 日韩人妻高清精品专区| 成年女人永久免费观看视频| 国产美女午夜福利| 亚洲国产日韩欧美精品在线观看 | 日韩高清综合在线| 九色国产91popny在线| 成年女人看的毛片在线观看| www.999成人在线观看| 真人一进一出gif抽搐免费| 欧美一级a爱片免费观看看| 亚洲成人久久性| a级毛片a级免费在线| 久久精品国产99精品国产亚洲性色| 搞女人的毛片| 一区福利在线观看| 国产99白浆流出| 国产91精品成人一区二区三区| 一区二区三区免费毛片| 亚洲国产精品久久男人天堂| 国产精品亚洲一级av第二区| 99热只有精品国产| 99riav亚洲国产免费| 亚洲在线观看片| 精品一区二区三区视频在线观看免费| 亚洲av免费在线观看| 成人av在线播放网站| 午夜日韩欧美国产| 无遮挡黄片免费观看| 最近最新中文字幕大全免费视频| 蜜桃亚洲精品一区二区三区| 日韩精品中文字幕看吧| 国产精品av视频在线免费观看| 久久久久国内视频| 啦啦啦观看免费观看视频高清| 大型黄色视频在线免费观看| av在线天堂中文字幕| 国产v大片淫在线免费观看| 欧美不卡视频在线免费观看| 高清日韩中文字幕在线| 国产亚洲av嫩草精品影院| 成人精品一区二区免费| 91av网一区二区| 一区二区三区免费毛片| 中文字幕久久专区| 男人舔奶头视频| 精品免费久久久久久久清纯| 欧洲精品卡2卡3卡4卡5卡区| 国产精品久久久久久久电影 | 日本在线视频免费播放| 99视频精品全部免费 在线| 五月玫瑰六月丁香| 国产亚洲欧美在线一区二区| 成年免费大片在线观看| 波野结衣二区三区在线 | 欧美成人性av电影在线观看| 九色国产91popny在线| 久久欧美精品欧美久久欧美| 欧美成人性av电影在线观看| 久久久久精品国产欧美久久久| 日本黄大片高清| 丰满乱子伦码专区| 女人被狂操c到高潮| 欧美不卡视频在线免费观看| 色吧在线观看| av女优亚洲男人天堂| netflix在线观看网站| av国产免费在线观看| 亚洲av熟女| 中文在线观看免费www的网站| 老汉色∧v一级毛片| 欧美一区二区国产精品久久精品| 91麻豆av在线| 亚洲电影在线观看av| or卡值多少钱| 国产精品永久免费网站| 亚洲国产高清在线一区二区三| 日韩欧美三级三区| 免费在线观看亚洲国产| 亚洲色图av天堂| 国产黄a三级三级三级人| 美女高潮的动态| h日本视频在线播放| 床上黄色一级片| 99久国产av精品| 亚洲精品在线美女| 中文字幕熟女人妻在线| 国产av一区在线观看免费| 成人国产一区最新在线观看| 午夜亚洲福利在线播放| 精品人妻一区二区三区麻豆 | 黑人欧美特级aaaaaa片| 2021天堂中文幕一二区在线观| 母亲3免费完整高清在线观看| 久久国产精品人妻蜜桃| 波多野结衣高清无吗| 国产精品久久视频播放| 一级毛片女人18水好多| 美女免费视频网站| 亚洲av免费高清在线观看| 中文资源天堂在线| 欧美黄色片欧美黄色片| 在线看三级毛片| 久久国产精品影院| 国产精品爽爽va在线观看网站| 高清在线国产一区| 亚洲av成人不卡在线观看播放网| а√天堂www在线а√下载| 中文字幕人妻熟人妻熟丝袜美 | 最后的刺客免费高清国语| 人人妻人人看人人澡| 国产精品久久久久久精品电影| 51国产日韩欧美| 亚洲av二区三区四区| 淫秽高清视频在线观看| 亚洲天堂国产精品一区在线| 人人妻人人澡欧美一区二区| 久久天躁狠狠躁夜夜2o2o| 真人做人爱边吃奶动态| 最新中文字幕久久久久| 在线观看免费午夜福利视频| 麻豆成人av在线观看| 亚洲国产高清在线一区二区三| 久久精品夜夜夜夜夜久久蜜豆| 午夜福利在线观看吧| 脱女人内裤的视频| 亚洲国产精品sss在线观看| 亚洲欧美日韩高清专用| www日本在线高清视频| 久久精品国产清高在天天线| 国产亚洲欧美98| 日韩中文字幕欧美一区二区| 国产黄色小视频在线观看| 人妻丰满熟妇av一区二区三区| 最好的美女福利视频网| 国产亚洲精品久久久com| 国产精品乱码一区二三区的特点| 国产成年人精品一区二区| 久久草成人影院| 日韩免费av在线播放| 欧美zozozo另类| 一区二区三区国产精品乱码| 一进一出好大好爽视频| 18禁黄网站禁片午夜丰满| 女同久久另类99精品国产91| 免费大片18禁| 国产精品电影一区二区三区| 国产主播在线观看一区二区| 久久久久性生活片| 国产99白浆流出| 亚洲欧美日韩卡通动漫| 一区二区三区国产精品乱码| 国产精品,欧美在线| 国产精品久久久久久久久免 | 黄色丝袜av网址大全| 亚洲国产精品sss在线观看| 欧美日韩一级在线毛片| 一级黄色大片毛片| 午夜亚洲福利在线播放| 成人一区二区视频在线观看| 国产精品久久久久久精品电影| 两人在一起打扑克的视频| 日本黄大片高清| www.www免费av| 欧美日韩瑟瑟在线播放| 九九热线精品视视频播放| 精品一区二区三区av网在线观看| eeuss影院久久| 亚洲成a人片在线一区二区| 免费在线观看影片大全网站| 十八禁人妻一区二区| 国产精品乱码一区二三区的特点| 成人特级av手机在线观看| 午夜久久久久精精品| 丁香欧美五月| 97超级碰碰碰精品色视频在线观看| 1000部很黄的大片| 亚洲五月天丁香| 欧美日韩瑟瑟在线播放| 舔av片在线| 99久久精品一区二区三区| 99热只有精品国产| 久久伊人香网站| 女人高潮潮喷娇喘18禁视频| 18禁黄网站禁片午夜丰满| 亚洲电影在线观看av| 一个人观看的视频www高清免费观看| 成人永久免费在线观看视频| 99在线人妻在线中文字幕| 日本一本二区三区精品| 草草在线视频免费看| 欧美丝袜亚洲另类 | 99riav亚洲国产免费| 国产精品,欧美在线| 欧美一级毛片孕妇| 波多野结衣高清无吗| 亚洲av免费高清在线观看| 变态另类成人亚洲欧美熟女| 丝袜美腿在线中文| 欧美乱色亚洲激情| 亚洲无线在线观看| 免费人成在线观看视频色| 丰满人妻一区二区三区视频av | 国产免费男女视频| a级毛片a级免费在线| 亚洲欧美日韩高清在线视频| 宅男免费午夜| 欧美国产日韩亚洲一区| www日本黄色视频网| 久久精品国产99精品国产亚洲性色| 国产精品影院久久| 熟女人妻精品中文字幕| 每晚都被弄得嗷嗷叫到高潮| 给我免费播放毛片高清在线观看| h日本视频在线播放| 69av精品久久久久久| 伊人久久精品亚洲午夜| 免费看美女性在线毛片视频| 国产精品野战在线观看| 国产黄a三级三级三级人| 精品国内亚洲2022精品成人| 免费高清视频大片| 高潮久久久久久久久久久不卡| 国产精品,欧美在线| 亚洲第一电影网av| 精品国产三级普通话版| 欧美极品一区二区三区四区| 在线视频色国产色| 色视频www国产| 99国产极品粉嫩在线观看| 亚洲人与动物交配视频| 精品一区二区三区人妻视频| 高清毛片免费观看视频网站| 国产精品亚洲一级av第二区| 一边摸一边抽搐一进一小说| 国产毛片a区久久久久| 免费看美女性在线毛片视频| 一本综合久久免费| 嫩草影院精品99| 国产亚洲精品综合一区在线观看| 国产成年人精品一区二区| 日本在线视频免费播放| 热99在线观看视频| 国产av一区在线观看免费| 草草在线视频免费看| 久久久久精品国产欧美久久久| 黄色女人牲交| 黄色丝袜av网址大全| 亚洲激情在线av| 亚洲在线自拍视频| 亚洲国产欧洲综合997久久,| 最新美女视频免费是黄的| www.色视频.com| 制服人妻中文乱码| 黄片小视频在线播放| 一本精品99久久精品77| 免费电影在线观看免费观看| 精品久久久久久久久久久久久| 国产不卡一卡二| 亚洲avbb在线观看| 草草在线视频免费看| 亚洲av不卡在线观看| 少妇丰满av| 亚洲国产精品久久男人天堂| 国产伦精品一区二区三区视频9 | 特级一级黄色大片| 51午夜福利影视在线观看| 国内精品一区二区在线观看| 丝袜美腿在线中文| 日本成人三级电影网站| 毛片女人毛片| 日本黄大片高清| 亚洲人成电影免费在线| 日韩免费av在线播放| 少妇人妻精品综合一区二区 | 国产精品日韩av在线免费观看| 成人欧美大片| a级毛片a级免费在线| 久久久久免费精品人妻一区二区| 免费观看人在逋| 久久久久国产精品人妻aⅴ院| 一个人观看的视频www高清免费观看| 免费av不卡在线播放|